AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10849267
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Interferon-a2a (IFN) with oral ganciclovir
Trial: 9089855
Drug: Clonidine 5
RxNorm normalized name: apraclonidine 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 5 micrograms/mL with lidocaine 1.5%
Trial: 9089855
Drug: Epinephrine 5
RxNorm normalized name: epinephrine 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epinephrine 5 micrograms/mL with lidocaine 1.5%
Trial: 30600521
Drug: Thula Baba
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thula Baba Box (TBB) and monthly Community Health Worker (CHW) visits
Trial: 29970875
Drug: Breviscapine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breviscapine (40 mg)
Trial: 21950300
Drug: Oral Methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral Methotrexate (MTX) 2.5 mg daily for 4 weeks
Trial: 21950300
Drug: Oral Methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral Methotrexate (MTX) weekly (not specified dosage)
Trial: 21950300
Drug: Oral Methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral Methotrexate (MTX) daily
Trial: 21950300
Drug: Oral Methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral Methotrexate (MTX) weekly
Trial: 18449064
Drug: 0.25% chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25% chlorhexidine solution
Trial: 18449064
Drug: 0.50% chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.50% chlorhexidine solution
Trial: 18449064
Drug: 1.00% chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.00% chlorhexidine solution
Trial: 16540246
Drug: Adequate antipsychotic
RxNorm normalized name: Adequan
DrugBank: Polysulfated glycosaminoglycan (DB11538)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adequate antipsychotic treatment
Trial: 12488289
Drug: Single 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 6 mg subcutaneous injection of pegfilgrastim
Trial: 12488289
Drug: Daily 5
RxNorm normalized name: Walgreens Gold Seal One Daily 50 Plus Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily 5 mg/kg subcutaneous injections of filgrastim
Trial: 11403727
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR 100 mg/day
Trial: 9517526
Drug: rice ORS
RxNorm normalized name: Rice
DrugBank: Rice (DB10563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rice ORS containing 50 g/l rice and 70 mmol/l Na+
Trial: 9517526
Drug: ORS containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ORS containing 70 mmol/l Na+ and 16.2 g/l glucose
Trial: 9517526
Drug: rice ORS
RxNorm normalized name: Rice
DrugBank: Rice (DB10563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rice ORS containing 50 g/l rice and 90 mmol/l Na+
Trial: 3140683
Drug: Metrifonate (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metrifonate (10 mg/kg x 3 doses)
Trial: 3140683
Drug: Praziquantel (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel (40 mg/kg x 1 dose)
Trial: 23883816
Drug: Synthetic bioabsorbable
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic bioabsorbable antibiotic-soaked nasal sponge in the middle meatus (MM)
Trial: 23883816
Drug: Conventional postoperative
RxNorm normalized name: ENSURE SURGERY PERIOPERATIVE KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional postoperative oral antibiotic prophylaxis (1 week) and saline-soaked bioabsorbable MM sponge
Trial: 21039936
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B at 3 mg kg(‐1) QD for 14 days, followed by 3 mg kg(‐1) QD
Trial: 21039936
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B at 10 mg kg(‐1) QD for 14 days, followed by 3 mg kg(‐1) QD
Trial: 7837745
Drug: Control glucose-nitrate
RxNorm normalized name: GLUCOSE CONTROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control glucose-nitrate solution
Trial: 27901334
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (MC and ALA)
Trial: 24708696
Drug: Subcutaneous (SC)
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous (SC) therapy
Trial: 18661082
Drug: 3% mepivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% mepivacaine hydrochloride injection
Trial: 12598719
Drug: Bifidobacterium-administered group
RxNorm normalized name: BIFIDOBACTERIUM
DrugBank: Bifidobacterium spp. (DB18530)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bifidobacterium-administered group (oral administration of lyophilized bifidobacteria, Bifidobacterium breve M‐16V strain)
Trial: 12598719
Drug: Bifidobacterium-administered group
RxNorm normalized name: BIFIDOBACTERIUM
DrugBank: Bifidobacterium spp. (DB18530)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bifidobacterium-administered group
Trial: 8693541
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg OKT3
Trial: 1657197
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment of alcoholics and drug addicts
Trial: 1657197
Drug: Separate treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate treatment of alcoholics and drug addicts
Trial: 31841507
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (100,000 IU loading dose followed by 20,000 IU/week)
Trial: 24786928
Drug: Open-label MEP
RxNorm normalized name: strontium chloride, 89Sr-labeled
DrugBank: Strontium chloride Sr-89 (DB09498)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label MEP treatment
Trial: 24786928
Drug: MEP (more
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MEP (more aggressive therapy)
Trial: 22424948
Drug: Cycled parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cycled parenteral nutrition (n = 34)
Trial: 22424948
Drug: Continuous parenteral
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous parenteral nutrition (n = 36)
Trial: 21061393
Drug: 0.1% capsaicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% capsaicin cream
Trial: 12078912
Drug: Two cycles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two cycles of chemotherapy (CT) with (sub)total nodal irradiation (RT) as consolidation treatment.
Trial: 12078912
Drug: Early intensive
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early intensive therapy including intensified cytoreductive CT and high-dose CT with autologous stem-cell transplantation.
Trial: 12078912
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment of eight doxorubicin-bleomycin-vinblastine-dacarbazine.
Trial: 31324862
Drug: Neostigmine 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 0.05 mg/kg
Trial: 10422928
Drug: Neostigmine 0.07
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 0.07 mg/kg
Trial: 10422928
Drug: Neostigmine 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 0.05 mg/kg after 2 min
Trial: 10422928
Drug: Neostigmine 0.07
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 0.07 mg/kg after 2 min
Trial: 10422928
Drug: Neostigmine 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 0.05 mg/kg after 5 min
Trial: 10422928
Drug: Neostigmine 0.07
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 0.07 mg/kg after 5 min
Trial: 479384
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg dezocine
Trial: 29113731
Drug: Oral fexinidazole
RxNorm normalized name: fexinidazole
DrugBank: Fexinidazole (DB12265)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral fexinidazole (1800 mg on days 1-4, 1200 mg on days 5-10)
Trial: 29113731
Drug: Nifurtimox eflornithine
RxNorm normalized name: nifurtimox
DrugBank: Nifurtimox (DB11820)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifurtimox eflornithine combination therapy (15 mg/kg per day for 10 days, 400 mg/kg per day for 7 days)
Trial: 29113731
Drug: Nifurtimox eflornithine
RxNorm normalized name: nifurtimox
DrugBank: Nifurtimox (DB11820)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifurtimox eflornithine combination therapy
Trial: 23085245
Drug: Lovastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin (40 mg daily)
Trial: 18977983
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with desmopressin and extended-release anticholinergic medication
Trial: 8632337
Drug: Pindolol administration
RxNorm normalized name: Pindolol
DrugBank: Pindolol (DB00960)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pindolol administration (10 mg twice daily) with NH4Cl (1.5 g every 6 hr)
Trial: 8632337
Drug: Control phase:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control phase: Pindolol administration (10 mg twice daily) without NH4Cl
Trial: 17137759
Drug: Typical antipsychotics
RxNorm normalized name: benzocaine Mucous Membrane Topical Solution [Topicale]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typical antipsychotics (oral and depot)
Trial: 2368243
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (absolute controls)
Trial: 519269
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment with medication monitor
Trial: 29173199
Drug: n-3 fatty
RxNorm normalized name: n-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 fatty acids (3.7 g daily)
Trial: 26209000
Drug: LCZ696 (dual‐acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LCZ696 (dual‐acting angiotensin receptor blocker and neprilysin inhibitor)
Trial: 12074617
Drug: Steroid (Depo‐Medrone)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid (Depo‐Medrone) injection preoperatively
Trial: 8175411
Drug: Radiotherapy for
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radiotherapy for left sided breast cancer (either tangential field 60Co or electron-therapy)
Trial: 6439699
Drug: Photon radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Photon radiation therapy
Trial: 30482511
Drug: First trimester
RxNorm normalized name: Cow first milk
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First trimester tear osmolarity measurement (304.9 ± 8.0 mOsm/L)
Trial: 30482511
Drug: Last trimester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Last trimester tear osmolarity measurement (300.2 ± 7.1 mOsm/L)
Trial: 28112433
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (medication management)
Trial: 25847775
Drug: Huanshuai Recipe
RxNorm normalized name: SALICYLIC ACID 1 g in 100 mL TOPICAL SHAMPOO [Maetria Miracle Recipe PremiumShampoo]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Huanshuai Recipe Oral Liquid (HSR), 20 mL, 3 times a day for 6 months
Trial: 21392111
Drug: Talaporfin sodium
RxNorm normalized name: Talaporfin
DrugBank: Talaporfin (DB11812)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Talaporfin sodium (0.25-1.0 mg/kg)
Trial: 18490847
Drug: Pre-germinated brown
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-germinated brown rice (PGBR) diet (3 packs of cooked PGBR, 180 g/pack daily for 6 weeks)
Trial: 18490847
Drug: White rice
RxNorm normalized name: White Rice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: White rice (WR) diet (3 packs of cooked WR, 180 g/pack daily for 6 weeks)
Trial: 11506111
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg morphine infiltrated into the harvest site
Trial: 11506111
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg intramuscular morphine
Trial: 8321112
Drug: L-carnitine (CARN)
DrugBank: Levocarnitine (DB00583)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-carnitine (CARN) 3 g.d-1 for 7 d
Trial: 8321112
Drug: L-carnitine (CARN)
DrugBank: Levocarnitine (DB00583)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-carnitine (CARN)
Trial: 3790647
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg Pindolol
Trial: 3790647
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg Cloxazolam
Trial: 3790647
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg Pindolol + 1.5 mg Cloxazolam
Trial: 11573527
Drug: Phenylephrine 4
RxNorm normalized name: GFN 600/Phenylephrine 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine 4 mg i.m.
Trial: 11573527
Drug: Phenylephrine 2
RxNorm normalized name: phenylephrine 2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine 2 mg i.m.
Trial: 11573527
Drug: Ephedrine 45
RxNorm normalized name: pseudoephedrine 45 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ephedrine 45 mg i.m.
Trial: 29298938
Drug: Facial photos
RxNorm normalized name: sulfur
DrugBank: Octasulfur (DB09353)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Facial photos taken 2 h after injection with 2.0 ng kg‐1 lipopolysaccharide (bacterial stimulus)
Trial: 29298938
Drug: Facial photos
RxNorm normalized name: sulfur
DrugBank: Octasulfur (DB09353)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Facial photos taken 2 h after injection with placebo
Trial: 27354761
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate intranasal steroid
Trial: 27354761
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate intranasal steroid
Trial: 19785605
Drug: Topical miltefosine
RxNorm normalized name: Miltefosine
DrugBank: Miltefosine (DB09031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical miltefosine and clobetasol
Trial: 19785605
Drug: Topical miltefosine
RxNorm normalized name: Miltefosine
DrugBank: Miltefosine (DB09031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical miltefosine
Trial: 17431777
Drug: Adefovir 10
RxNorm normalized name: adefovir 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adefovir 10 mg/day (Group 1)
Trial: 17431777
Drug: Adefovir 10
RxNorm normalized name: adefovir 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adefovir 10 mg/day and lamivudine 100 mg once daily (Group 2)
Trial: 16280250
Drug: Levetiracetam (1,000-4,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levetiracetam (1,000-4,000 mg/day)
Trial: 16280250
Drug: Levetiracetam monotherapy
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam monotherapy
Trial: 15790985
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 500 microg twice daily
Trial: 9949318
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 1000 microg twice daily
Trial: 2262582
Drug: Triclosan containing
RxNorm normalized name: Triclosan
DrugBank: Triclosan (DB08604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triclosan containing oral hygiene products
Trial: 2262582
Drug: Stannous fluoride
RxNorm normalized name: Stannous Fluoride
DrugBank: Stannous fluoride (DB11092)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Stannous fluoride containing oral hygiene products
Trial: 31192643
Drug: Parents who
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parents who received additional guidance to focus on teaching numbers during tablet play.
Trial: 31192643
Drug: Parents who
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parents who did not receive additional guidance to focus on teaching numbers during tablet play.
Trial: 26367529
Drug: High protein
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High protein diet (2.4 g protein/kg/d)
Trial: 26367529
Drug: Low protein
RxNorm normalized name: Low protein mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low protein diet (0.4 g protein/kg/d)
Trial: 22518934
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C treatment group (1000 mg d(‐1))
Trial: 17410435
Drug: mesalazine, 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mesalazine, 800 mg bid
Trial: 17410435
Drug: mesalazine, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mesalazine, 400 mg bid
Trial: 17410435
Drug: rifaximin, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rifaximin, 200 mg bid
Trial: 17410435
Drug: rifaximin, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rifaximin, 400 mg bid
Trial: 3593994
Drug: Domperidone (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (0.1 mg X kg‐1 i.v.)
Trial: 30297759
Drug: Cooked cream
RxNorm normalized name: egg shell, cooked
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cooked cream of rice cereal (CR)
Trial: 30297759
Drug: Cooked cream
RxNorm normalized name: egg shell, cooked
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cooked cream of rice cereal with sugar, nuts, and seeds (CRsns)
Trial: 26081100
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg CoQ10 twice daily for 1 week
Trial: 19465123
Drug: Celecoxib 200mg
RxNorm normalized name: CELECOXIB 200MG CAP
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Celecoxib 200mg capsules in the fed state
Trial: 19465123
Drug: Celecoxib 200mg
RxNorm normalized name: CELECOXIB 200MG CAP
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Celecoxib 200mg capsules in the fasted state
Trial: 8676529
Drug: Abrupt discontinuation
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abrupt discontinuation of TPN
Trial: 8676529
Drug: Tapering of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapering of TPN (decreasing infusion rate by 50% for 1 hour before discontinuation)
Trial: 6475824
Drug: Inorganic iron,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inorganic iron, 920 mumol (51 mg)
Trial: 6475824
Drug: HB iron,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HB iron, 480 mumol (26 mg)
Trial: 6475824
Drug: Inorganic iron,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inorganic iron, 610 mumol (34 mg)
Trial: 6475824
Drug: Tin, 306
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tin, 306 mumol (36 mg)
Trial: 6475824
Drug: Copper, 79
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Copper, 79 mumol (5 mg)
Trial: 31106336
Drug: Cardiac resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac resynchronization therapy (CRT) defibrillating device
Trial: 31106336
Drug: Cardiac resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac resynchronization therapy (CRT) pacer
Trial: 23677249
Drug: Desmopressin melt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin melt (120/240 μg)
Trial: 23677249
Drug: Desmopressin tablet
RxNorm normalized name: desmopressin Sublingual Tablet
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Desmopressin tablet (0.2/0.4 mg)
Trial: 21843943
Drug: Weekly nab-paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Weekly nab-paclitaxel (150 mg/m2)
Trial: 15142029
Drug: Mg(2+)-Cr group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mg(2+)-Cr group (2.5 g of Cr daily)
Trial: 15142029
Drug: Cr group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cr group (2.5 g of Cr daily)
Trial: 12074415
Drug: Bupivacaine 0.2%
RxNorm normalized name: BUPivacaine 0.2%-NaCl 0.9% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.2% with fentanyl 2 microg mL(‐1)